Pfizer Payment for (Proceeds from) Other Investing Activity decreased by 57.1% to -$22.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 92.7%, from -$300.00M to -$22.00M.
Large fluctuations may indicate one-time events or non-recurring financial adjustments that require further investigation.
Captures miscellaneous cash flows related to investing activities that do not fit into standard categories like capital...
Often used as a catch-all category in cash flow statements across various sectors.
other_payments_for_proceeds_from_other_investing_activities| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $235.00M | $298.00M | $13.00M | $78.00M | $109.00M | $0.00 | $18.00M | $525.00M | $0.00 | $18.00M | -$5.00M | -$15.00M | -$300.00M | -$14.00M | -$22.00M |
| QoQ Change | — | +26.8% | -95.6% | +500.0% | +39.7% | -100.0% | — | >999% | -100.0% | — | -127.8% | -200.0% | <-999% | +95.3% | -57.1% |
| YoY Change | — | — | — | -66.8% | -63.4% | — | +38.5% | +573.1% | -100.0% | -96.6% | — | — | — | -180.0% | +92.7% |